HELX | Franklin Genomic Advancements ETF Overview

(Stock Exchange: BATS)

Day's Range	33.14 - 33.15
52 Week Range	25.26 - 33.98
Beta	1.05
Implied Volatility	22.64%
IV Rank	13.95%
Day's Volume	17
Average Volume	2,239
Shares Outstanding	302,164
Inception Date	2020-02-27

Assets	9,699,000
Asset Class	Equity
Expense Ratio	0.50
P/E Ratio	21.63
EPS	1.53
Dividend Yield	0.01%
Dividend Per Share	0.00
Dividend ExDate	N/A
Dividend PayDate	N/A

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

*Chart delayed

Watching at HELX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on HELX Technicals page.